May 4, 2023

The American College of Radiology® (ACR®) expressed concern about the decision by the Centers for Medicare and Medicaid Services (CMS) to retroactively remove CPT® codes 0554T-0558T (biomechanical computed tomography (BCT) analysis) from the National Coverage Decision (NCD) 150.3 Bone Density Studies. These CPT codes describe services used for determining bone density using the FDA-cleared bone densitometer.

In its latest policy guidance, CMS non-covers biomechanical computed tomography (BCT) analysis retroactive to July 2019. The College seeks guidance from CMS on how healthcare providers should handle claims using these codes going forward. We believe that claims paid using these codes should not be adjusted unless there is concern that these services were not properly furnished.

The ACR and other specialty societies continue to engage with CMS to improve public notice and comment opportunities for coverage and policy articles. The change in coverage status for CPT codes 0554T-0558T retrospective to July 2019 proves existing processes are not adequate.

For questions on Medicare Coverage processes, contact Alicia Blakey, ACR Principal Economic Policy Analyst.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more